ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Mangoceuticals Inc

Mangoceuticals Inc (MGRX)

0.3199
-0.0202
(-5.94%)
Closed June 16 4:00PM
0.322
0.0021
(0.66%)
After Hours: 7:59PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.322
Bid
0.3011
Ask
0.38
Volume
509,983
0.30 Day's Range 0.35
0.143 52 Week Range 1.99
Market Cap
Previous Close
0.3401
Open
0.3456
Last Trade Time
Financial Volume
$ 164,896
VWAP
0.323335
Average Volume (3m)
5,483,561
Shares Outstanding
17,039,500
Dividend Yield
-
PE Ratio
-0.59
Earnings Per Share (EPS)
-0.54
Revenue
731k
Net Profit
-9.21M

About Mangoceuticals Inc

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was i... Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Show more

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
Headquarters
Dallas, Texas, USA
Founded
1970
Mangoceuticals Inc is listed in the Health & Allied Services sector of the NASDAQ with ticker MGRX. The last closing price for Mangoceuticals was $0.34. Over the last year, Mangoceuticals shares have traded in a share price range of $ 0.143 to $ 1.99.

Mangoceuticals currently has 17,039,500 shares outstanding. The market capitalization of Mangoceuticals is $5.45 million. Mangoceuticals has a price to earnings ratio (PE ratio) of -0.59.

MGRX Latest News

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

Dallas, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances

MOJO to be offered as an Oral Dissolvable Tablet (ODT) marketed to younger male demographic as an alternative to PRIME Testosterone Replacement Therapy (TRT) Dallas, Texas, June 04, 2024 (GLOBE...

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

Dallas, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

Dallas, TX, May 23, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

Formulations to be marketed as “Slim” and “Trim” as an Oral Dissolvable Tablet (ODT) Dallas, TX, May 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0446-12.16584833610.36660.44390.310087220.40779722CS
40.08234.16666666670.241.120.215163148720.49566596CS
120.122610.21.120.1754835610.48926572CS
26-0.278-46.33333333330.61.120.14331373000.45083641CS
52-1.238-79.3589743591.561.990.14316774040.48860829CS
156-3.878-92.33333333334.24.26940.14319917970.82668755CS
260-3.878-92.33333333334.24.26940.14319917970.82668755CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 5.96
(338.24%)
70.99M
LRHCLa Rosa Holdings Corporation
$ 1.165
(90.61%)
40.6M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
BRFHBarfresh Food Group Inc
$ 3.03
(38.36%)
247.31k
NNENano Nuclear Energy Inc
$ 9.37
(32.53%)
1.77M
NXLNexalin Technologies Inc
$ 0.89
(-35.52%)
3.93M
INABIN8bio Inc
$ 1.095
(-34.82%)
4.92M
QXOQXO Inc
$ 134.10
(-34.71%)
142.29k
GANXGain Therapeutics Inc
$ 1.24
(-34.39%)
3.09M
KYTXKyverna Therapeutics Inc
$ 9.52
(-34.07%)
4.31M
NVDANVIDIA Corporation
$ 131.88
(1.75%)
309.34M
SVMHSRIVARU Holding Ltd
$ 0.227586
(49.24%)
276.03M
KITTNauticus Robotics Inc
$ 0.1921
(19.69%)
165.83M
CRKNCrown Electrokinetics Corporation
$ 0.0582
(-21.35%)
136.77M
SQQQProShares UltraPro Short QQQ
$ 8.43
(-1.29%)
112.46M

MGRX Discussion

View Posts
valleybenedetto valleybenedetto 22 hours ago
Mango written up by JP Morgan Fund!

https://athletechnews.com/jp-morgan-targets-weight-loss-drugs-with-500m-fund/?s=09
👍️ 1 💯 1
Golden Cross Golden Cross 2 weeks ago
$MGRX MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances https://www.stocktitan.net/news/MGRX/mango-rx-to-introduce-mojo-pharmaceutical-compounded-formula-xetrg1zk54sn.html
💩 1 🤡 1
Carjockey2 Carjockey2 3 weeks ago
Haaaaa..

I am the new crypto coin gal..

Lol
👍️0
valleybenedetto valleybenedetto 3 weeks ago
Trade em up. No more marriages
👍️0
Carjockey2 Carjockey2 3 weeks ago
Nice news but I'm done with this one.

👍️0
valleybenedetto valleybenedetto 3 weeks ago
Nice news today. Partnered with CrakMedia..same firm that brought BlueChew to 200m revs
👍️0
Carjockey2 Carjockey2 4 weeks ago
Again...

Don't include me on your posts like you did all day today..

Does that work for you..works for me..

Cyber stalking is illegal...

Back to your 4 jobs you go..

👍️0
crowin crowin 4 weeks ago
Again my point that everything is about you!

Get back with the family, they miss you!


Please keep your post about MGRX.
👍️0
Carjockey2 Carjockey2 4 weeks ago
LMAO

You have had time to stalk me for 10 years..YES 10 years..


I am happily retired..

No 4 jobs for me..

Follow the right traders you won't have to work 4 jobs..

After following me for 10 years you should be happily retired with your family what have you been doing wrong







👍️0
crowin crowin 4 weeks ago
I Have a life and do not hang out around here allday, just mornings.

What is wrong with that ?

Take care of the family like i do.

4 business and family is my priority...
Whats yours?
👍️0
crowin crowin 4 weeks ago
Everything you post is about you. Stop it!

You missed out today for a quick buck.

Whats next?

Stop stalking me when I make money without you!
Go and enjoy the Grand baby!

Granny, will you please focus on me and not IHUB!

I miss you granny......
👍️0
Carjockey2 Carjockey2 4 weeks ago
If you I really owned shares here you wouldn't be posting five times to me on a board you'd be celebrating, so I guess we know what's up..

We all know you stalk me but that's even crazy..
👍️0
Carjockey2 Carjockey2 4 weeks ago
Lolzzzz

Awesome day here..

$MGRX


What's weee??

This was your last post in February..lol

Reverse Stock split to risky here

Silly bird.. is it difficult pretending you own shares of something you hated when it runs???
👍️0
Carjockey2 Carjockey2 4 weeks ago
Great day everybody congratulations..

$MGRX got a bona..

😉
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: Are my MGRX shares 'rising-from-the-ashes' now, following a rather disappointing Close today??? (At 32% UP in the Post-M right now, might be so.)
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: Hey "Invest-in-America", CLOWN!! Why don't you flush your pet PUSSYCAT down that toilet, FOOL!!! (Which is likely the ONLY 'pussy' you ever got, STUPID!!) WHY??? Because our MGRX COMEBACK is gonna make Tom Brady's look like those stupid 'BUCKS' of Florida never even scored ONE POINT in that game!!!
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: See today's final 'CHART', below!!

👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: Come on, you dead-cat, BOUNCE!!! For the sake of us BIG-FAT-&-GREASY Amerikanos!!! And heck, you have one pill to make mens' DICKS big & fat --- and now another pill to make their OBESITY-BODIES "slim & trim"!!! Why not do BOTH in just one, tasty, fat pill???!!!

////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
And see BELOW, what my own 'Personal Financial Planner' said to me early today, when I asked him what he thought about me tossin' some bucks at MGRX stock ---
👍️0
pumpnass pumpnass 4 weeks ago
No doubt, over 200 million shares traded and it can’t even get out of its own way now. All this volume it should be over 5 dollars but because the scam CEO made so many bad deals the funders are having a field day with the volatility
👍️0
CashCowMoo CashCowMoo 4 weeks ago
I would take the money and run too based on past performance (no pun intended)
👍️0
pumpnass pumpnass 4 weeks ago
Yea definitely did but if they knew what’s good for them take the money and run. That’s what I would do if I was still holding this trash
👍️0
CashCowMoo CashCowMoo 4 weeks ago
Well, if thats the case at least some people got some good flips in.
👍️0
pumpnass pumpnass 4 weeks ago
It will be back in the garage before you know it. This company is a complete scam starting with the CEO
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: From their PR today ---
https://www.globenewswire.com/news-release/2024/05/21/2885580/0/en/MangoRx-to-Introduce-Oral-Semaglutide-and-Tirzepatide-in-Response-to-Increasing-Patient-Demand-for-GLP-1-Medications.html
"We are thrilled to introduce 'Slim' and 'Trim', MangoRx's oral formulations of Semaglutide and Tirzepatide, to the weight loss market", said Jacob Cohen, CEO and Co-Founder of MangoRx. "Our goal is to provide patients with a convenient (vs. injections) and effective way to manage their weight and improve their overall health. We believe that these oral formulations have the potential to significantly impact the lives of millions of people worldwide." (Emphases & parenthesis added.)
///////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
CashCowMoo CashCowMoo 4 weeks ago
Looks like this has risen from the dead!
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: Doin' great, Colonel Tim!! And THANKS for that DD on their 52-wk-high. (Hey, on my first cursory read of their news today, I misinterpreted it as a NEW --- more convenient & cheaper --- form of their original SEX-related stuff!! But heck, being about WEIGHT LOSS is even better, IMO.)
👍️0
TIMGZ TIMGZ 4 weeks ago
MGRX TO $2.38 WHICH IS THE CURRENT 52 WK HIGH. MGRX HAS MANY IRON IN THE FIRE, WE SHALL SEE. LOOKS GOOD SO FAR****HOW ARE U********THAT YOURNEW LADY FRIEND LOOK HAPPY
👍️0
crowin crowin 4 weeks ago
Free shares from here on UP!
👍️0
powerbattles powerbattles 4 weeks ago
Out 1.02 +315.69% sweet ride!
👍️0
crowin crowin 4 weeks ago
MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

https://ih.advfn.com/stock-market/NASDAQ/mangoceuticals-MGRX/stock-news/93897231/mangorx-to-introduce-oral-semaglutide-and-tirzepat
👍️0
crowin crowin 4 weeks ago
HALTED at 293% gain at this time $1.12
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: If King Crowin is in here, you better KNOW that MGRX has for the very FIRST time gotten REALLY NOTICED across Wall Street, and BEYOND!!!
👍️0
crowin crowin 4 weeks ago
214% and keeps going
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX; INDEED!!! (Hey, all seriousness aside, this one is a minimum 10-bagger today!!! But look at the competition from that freak-show @MGOL!!!)
👍️0
tw0122 tw0122 4 weeks ago
MGRX chiks like those big SD guns…lol
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: Hey, Admiral TW-0122, you know that I have BASHED this Firm many times in the past behind the TYPE of lurid ads they were running, but I NEVER mocked their substantive PRODUCT. Hey, Bro, I myself have been using it for MONTHS now. Heck, last Friday night, at a swingin' singles bar over here in (balmy) San Diego, CA, the hot chick in the bar security cam below almost got me BUSTED, Dude!!! And only 5-minutes after I had gulped a FIST FULL of MRGX's new pills!!!!

👍️0
crowin crowin 4 weeks ago
UP UP UP Im getting dizzy
👍️0
crowin crowin 4 weeks ago
152% and rising
👍️0
tw0122 tw0122 4 weeks ago
ED to weight loss get hard then thin for the ladies a duo combo…lol


Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce the development of proprietary oral formulations of Semaglutide (“Slim”) and Tirzepatide (“Trim”) to aid in weight management. These innovative drugs, currently available predominantly in injectable form, have demonstrated remarkable efficacy in clinical trials. MangoRx’s new oral formulations are poised to revolutionize the weight loss market and capture significant market share.
The GLP-1 receptor agonists’ market, including both Semaglutide and Tirzepatide, is projected to reach over $164 billion in combined revenue by 2032, based on Visible Alpha consensus, ramping up from $37.9 billion in 2023. These are record-breaking revenues for any drug class in the history of drug development.

The oral formulations of Semaglutide and Tirzepatide are set to capture a significant share of this market, offering a convenient alternative to injections. Semaglutide, marketed under the brand names Ozempic® and Wegovy®, and Tirzepatide, marketed as Mounjaro® and Zepbound®, are both glucagon-like peptide-1 (GLP-1) receptor agonists. These drugs have demonstrated impressive weight loss results in clinical trials. In a recent study, patients taking Semaglutide achieved an average weight loss of 15.2% over one year, while those taking Tirzepatide experienced an average weight loss of 15.7%. The oral formulations of Semaglutide and Tirzepatide are designed for daily consumption and are expected to provide similar weight loss benefits without the need for regular injections.

Patient preference studies consistently show a significant majority in favor of oral medications over injectables. This preference is anticipated to drive higher adoption rates and expand the existing market. The shift to an oral formulation offers a more accessible and convenient option for patients, potentially increasing adherence and overall treatment success.

“We are thrilled to introduce ‘Slim’ and ‘Trim’, MangoRx’s oral formulations of Semaglutide and Tirzepatide, to the weight loss market,” said Jacob Cohen, CEO and Co-Founder of MangoRx. “Our goal is to provide patients with a convenient and effective way to manage their weight and improve their overall health. We believe that these oral formulations have the potential to significantly impact the lives of millions of people worldwide.”

MangoRx plans to have the products available for customers on the company’s telemedicine platform in the beginning of the 3rd quarter with ‘Slim’ and ‘Trim’ competitively priced at $299/month and $399/month, respectively. MangoRx is committed to advancing the treatment of obesity and related conditions and is dedicated to improving the lives of patients worldwide.
👍️0
crowin crowin 4 weeks ago
Wee doggie Granny, were up 118% at this moment
👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: NOTHING can stop this Godzilla-Class-SOARING-Price today, Peeps!!!!

👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: 10-bagger minimum today, Homeboys!!!

👍️0
Invest-in-America Invest-in-America 4 weeks ago
MGRX: That news could get this one UP!!! (No sexual pun intended!!)

👍️0
powerbattles powerbattles 4 weeks ago
MGRX spike on new out +122%
👍️0
koolmc koolmc 2 months ago
nice bounce back after hitting .15's low in march
👍️0
krisc62 krisc62 3 months ago
Lol! What a clown!
👍️0
Invest-in-America Invest-in-America 3 months ago
MGRX: This circus sideshow carnival routine could still NOT get its PRICE 'UP' --- no sexual innuendo intended --- even if DONALD TRUMP had just tried their stuff & made World News Tonight by proclaiming that he got his first 'HARD-ON' since his last date with 'STORMY DANIELS' over 4-years ago!!!
👍️0
Monksdream Monksdream 3 months ago
Wash trade bot this morning
👍️0
6of1 6of1 3 months ago
the super bowl lie
👍️0
NorfolkIP NorfolkIP 3 months ago
What specifically makes it a “scam”?
👍️0

Your Recent History

Delayed Upgrade Clock